No recent analyst price targets found for ORTX.
Latest News for ORTX
Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA
Designation granted under Innovative Licensing and Access Pathway which aims to accelerate development of, and access to, transformative new medicines in the United Kingdom Designation granted under Innovative Licensing and Access Pathway which aims to accelerate development of, and access to, transformative new medicines in the United Kingdom
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ORTX.
U.S. House Trading
No House trades found for ORTX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.